BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21764886)

  • 21. Adverse prenatal environment and kidney development: implications for programing of adult disease.
    Dorey ES; Pantaleon M; Weir KA; Moritz KM
    Reproduction; 2014 Jun; 147(6):R189-98. PubMed ID: 24686455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments.
    Guilloteau P; Zabielski R; Hammon HM; Metges CC
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():17-35. PubMed ID: 19996479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of fetal programming for cardiovascular disease in adulthood.
    Leach L; Mann GE
    Microcirculation; 2011 May; 18(4):253-5. PubMed ID: 21418386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using ChIP-based technologies to identify epigenetic modifications in disease-relevant cells.
    Falk J
    IDrugs; 2010 Mar; 13(3):169-74. PubMed ID: 20191433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of oxidative stress during pregnancy on fetal epigenetic patterns and early origin of vascular diseases.
    Ávila JG; Echeverri I; de Plata CA; Castillo A
    Nutr Rev; 2015 Jan; 73(1):12-21. PubMed ID: 26024054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assisted reproductive technology, epigenetics, and long-term health: a developmental time bomb still ticking.
    Grace KS; Sinclair KD
    Semin Reprod Med; 2009 Sep; 27(5):409-16. PubMed ID: 19711251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes.
    Junien C; Nathanielsz P
    Obes Rev; 2007 Nov; 8(6):487-502. PubMed ID: 17949354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reproductive/Developmental Abnormalities Induced by Epigenetic Aberrations and Possible Environmental Causes].
    Kawai T; Hata K
    Nihon Eiseigaku Zasshi; 2016; 71(3):195-199. PubMed ID: 27725422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic control of fetal gene expression.
    Nafee TM; Farrell WE; Carroll WD; Fryer AA; Ismail KM
    BJOG; 2008 Jan; 115(2):158-68. PubMed ID: 17970798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic imprinting, programming and epigenetics - a review of present priorities and future opportunities.
    Hanley B; Dijane J; Fewtrell M; Grynberg A; Hummel S; Junien C; Koletzko B; Lewis S; Renz H; Symonds M; Gros M; Harthoorn L; Mace K; Samuels F; van Der Beek EM
    Br J Nutr; 2010 Jul; 104 Suppl 1():S1-25. PubMed ID: 20929595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Environmental epigenomics in human health and disease.
    Dolinoy DC; Jirtle RL
    Environ Mol Mutagen; 2008 Jan; 49(1):4-8. PubMed ID: 18172876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of genetic and epigenetic factors from early life to later disease.
    Tremblay J; Hamet P
    Metabolism; 2008 Oct; 57 Suppl 2():S27-31. PubMed ID: 18803962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex-specificity in transgenerational epigenetic programming.
    Dunn GA; Morgan CP; Bale TL
    Horm Behav; 2011 Mar; 59(3):290-5. PubMed ID: 20483359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics in Cardiovascular Regulation.
    Sartori C; Rimoldi SF; Rexhaj E; Allemann Y; Scherrer U
    Adv Exp Med Biol; 2016; 903():55-62. PubMed ID: 27343088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthma and pregnancy: emerging evidence of epigenetic interactions in utero.
    Prescott SL; Clifton V
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):417-26. PubMed ID: 19652594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nongenomic memory of foetal history in chronic diseases development.
    Bezek S; Ujhazy E; Dubovicky M; Mach M
    Neuro Endocrinol Lett; 2008 Oct; 29(5):620-6. PubMed ID: 18987584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics and cardiovascular risk in childhood.
    Martino F; Magenta A; Pannarale G; Martino E; Zanoni C; Perla FM; Puddu PE; Barillà F
    J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):539-46. PubMed ID: 27367935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early origins of adult disease: approaches for investigating the programmable epigenome in humans, nonhuman primates, and rodents.
    Ganu RS; Harris RA; Collins K; Aagaard KM
    ILAR J; 2012; 53(3-4):306-21. PubMed ID: 23744969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.